Drug therapies to reduce cardiovascular risk and prevent the onset of diabetes may be effective in the short term, but as people age, the efficacy of drugs like statins and metformin tends to diminish, while the risk of adverse effects increases. The benefit of nutritional and lifestyle interventions, on the other hand, remains robust even as people enter their final decades.
A new and interesting angle on the vitamin D story is emerging from research on weight gain in older women. The vitamin, it seems, is an important metabolic signal that indirectly regulates the propensity to store fat.
Elevated cholesterol and high blood glucose are the obvious features of diabetes and heart disease but they're hardly the whole picture. Other, less obvious factors including environmental toxins like BPA and lead, gastrointestinal disorders, and frequent use of artificial sweeteners are also important drivers of disease. According to Dr. Mark Hyman, author of the popular book, The Blood Sugar Solution, these oft-overlooked factors warrant closer attention.
Methylenetetrahydrofolate reductase (MTHFR) is one of the most important enzymes in human physiology, having influence on at least as many biochemical processes as it has syllables in its name. Deficiencies in this enzyme increase the risk of CVD, several types of cancer, congenital defects, and inflammatory bowel disease. Fortunately, deficiencies are correctable with targeted supplementation.
People with metabolic syndrome who add a soy-based "medical food" to a low-glycemic load Mediterranean-style diet can push the cardiometabolic benefits well beyond what is obtainable with the diet alone.
Sublingual immunotherapy is a safe, highly effective alternative to injection-based treatments for managing allergies. Moreover, it enables primary care physicians to treat patients that they are currently referring out to specialists.
Despite the Institute of Medicine's recent report, many nutrition-minded oncologists believe high-dose vitamin D supplementation—upwards of 4,000 IU/day—has potential to markedly reduce risk of primary breast cancer as well as breast cancer recurrence, with minimal risk of toxicity.